Ely Benaim
Net worth: 351 857 $ as of 2024-04-29
Career history of Ely Benaim
Former positions of Ely Benaim
| Companies | Position | Start | End |
|---|---|---|---|
| NOVOCURE LIMITED | Chief Tech/Sci/R&D Officer | 2019-03-31 | 2023-01-16 |
| REXAHN PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2015-01-31 | 2019-03-30 |
| Berg Pharma LLC | Chief Tech/Sci/R&D Officer | 2012-12-31 | 2014-12-31 |
| General Counsel | 2012-12-31 | 2014-12-31 | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2010-12-31 | 2012-12-31 |
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2007-03-31 | 2009-12-31 |
| University of Tennessee | Corporate Officer/Principal | - | - |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Corporate Officer/Principal | - | - |
Training of Ely Benaim
| Central University of Venezuela | Doctorate Degree |
Statistics
International
| United States | 7 |
| Venezuela | 2 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
| Berg Pharma LLC | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Ely Benaim
- Experience